Percutaneous coronary intervention with stenting in patients with atrial fibrillation research hub

Comparison of a low dose of the anticlotting drug apixaban with the standard dose of apixaban in patients with the heart rhythm disturbance known as atrial fibrillation who have undergone stenting treatment of their heart arteries and are intended to receive standard-dose apixaban along with another anticlotting drug, ticagrelor

This study compares two doses of a blood-thinning medicine, apixaban, when given with ticagrelor. It's for people with an irregular heartbeat (atrial fibrillation) who recently had heart stent surgery. We want to see if a lower dose is safer while still effective.